Case Study: Wren Therapeutics achieves faster purchasing and tighter spend controls with Procurify

Accelerating the Development of Vital Medications with Streamlined Purchasing

Wren Therapeutics is a Cambridge–Lund biotechnology company developing therapies for protein‑misfolding diseases such as Alzheimer’s and Parkinson’s. As the company scaled, finance controller Joe Wilson inherited a manual purchasing process driven by Excel, Word and email that caused slow purchase orders, weak spend controls, difficult invoice reconciliation, poor real‑time visibility into project spend, and time‑consuming month‑end closes.

Wren implemented Procurify to automate approvals, enforce customizable approval limits, provide mobile approvals and deliver real‑time spend analytics with PO‑to‑invoice matching. The result was near‑instant approvals (down from days), faster month‑end closes (saving a day or two), stronger financial controls and reconciliation, and more time for scientists to focus on research.

Wren Therapeutics

Joe Wilson

Financial Controller